These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 20400962)

  • 1. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.
    Bendle GM; Linnemann C; Hooijkaas AI; Bies L; de Witte MA; Jorritsma A; Kaiser AD; Pouw N; Debets R; Kieback E; Uckert W; Song JY; Haanen JB; Schumacher TN
    Nat Med; 2010 May; 16(5):565-70, 1p following 570. PubMed ID: 20400962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-swapped T cell receptors improve the safety of TCR gene therapy.
    Bethune MT; Gee MH; Bunse M; Lee MS; Gschweng EH; Pagadala MS; Zhou J; Cheng D; Heath JR; Kohn DB; Kuhns MS; Uckert W; Baltimore D
    Elife; 2016 Nov; 5():. PubMed ID: 27823582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput identification of antigen-specific TCRs by TCR gene capture.
    Linnemann C; Heemskerk B; Kvistborg P; Kluin RJ; Bolotin DA; Chen X; Bresser K; Nieuwland M; Schotte R; Michels S; Gomez-Eerland R; Jahn L; Hombrink P; Legrand N; Shu CJ; Mamedov IZ; Velds A; Blank CU; Haanen JB; Turchaninova MA; Kerkhoven RM; Spits H; Hadrup SR; Heemskerk MH; Blankenstein T; Chudakov DM; Bendle GM; Schumacher TN
    Nat Med; 2013 Nov; 19(11):1534-41. PubMed ID: 24121928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor gene therapy: critical parameters for clinical success.
    Linnemann C; Schumacher TN; Bendle GM
    J Invest Dermatol; 2011 Sep; 131(9):1806-16. PubMed ID: 21677669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.
    Bunse M; Bendle GM; Linnemann C; Bies L; Schulz S; Schumacher TN; Uckert W
    Mol Ther; 2014 Nov; 22(11):1983-91. PubMed ID: 25048215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced T cell receptor gene therapy for cancer.
    Kieback E; Uckert W
    Expert Opin Biol Ther; 2010 May; 10(5):749-62. PubMed ID: 20201709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
    Puig-Saus C; Parisi G; Garcia-Diaz A; Krystofinski PE; Sandoval S; Zhang R; Champhekar AS; McCabe J; Cheung-Lau GC; Truong NA; Vega-Crespo A; Komenan MDS; Pang J; Macabali MH; Saco JD; Goodwin JL; Bolon B; Seet CS; Montel-Hagen A; Crooks GM; Hollis RP; Campo-Fernandez B; Bischof D; Cornetta K; Gschweng EH; Adelson C; Nguyen A; Yang L; Witte ON; Baltimore D; Comin-Anduix B; Kohn DB; Wang X; Cabrera P; Kaplan-Lefko PJ; Berent-Maoz B; Ribas A
    Clin Cancer Res; 2019 Feb; 25(3):1000-1011. PubMed ID: 30409823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR validation toward gene therapy for cancer.
    Green EW; Bunse L; Bozza M; Sanghvi K; Platten M
    Methods Enzymol; 2019; 629():419-441. PubMed ID: 31727252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical development of T cell receptor gene therapy.
    Bendle GM; Haanen JB; Schumacher TN
    Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor gene therapy of established tumors in a murine melanoma model.
    Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA
    J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function.
    Thomas S; Mohammed F; Reijmers RM; Woolston A; Stauss T; Kennedy A; Stirling D; Holler A; Green L; Jones D; Matthews KK; Price DA; Chain BM; Heemskerk MHM; Morris EC; Willcox BE; Stauss HJ
    Nat Commun; 2019 Oct; 10(1):4451. PubMed ID: 31575864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.
    Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A
    Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting self-antigens through allogeneic TCR gene transfer.
    de Witte MA; Coccoris M; Wolkers MC; van den Boom MD; Mesman EM; Song JY; van der Valk M; Haanen JB; Schumacher TN
    Blood; 2006 Aug; 108(3):870-7. PubMed ID: 16861342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies.
    van Loenen MM; de Boer R; Hagedoorn RS; van Egmond EH; Falkenburg JH; Heemskerk MH
    Haematologica; 2011 Mar; 96(3):477-81. PubMed ID: 21109688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor gene-modified cells: past promises, present methodologies and future challenges.
    Tendeiro Rego R; Morris EC; Lowdell MW
    Cytotherapy; 2019 Mar; 21(3):341-357. PubMed ID: 30655164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease.
    Ferrara J; Reddy P; Paczesny S
    Immunotherapy; 2010 Nov; 2(6):791-4. PubMed ID: 21091111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy.
    D'Apice L; Cuccaro F; Varriale S; Cipria D; Sartorius R; Circosta P; Cignetti A; Salerno M; Coscia MR; Oreste U; Marzullo VM; Martini G; Acuto O; De Berardinis P
    J Immunother; 2019 May; 42(4):97-109. PubMed ID: 30865026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.